Remedy, which finally smiled on the KOSDAQ after three attempts, 7is slated to list in the third week of the month
Remedy has debuted on KOSDAQ after overcoming two failed listing attempts and making a third push. This listing is 7in the third week of the month (13~17day) and is included in the IPO schedule; the detailed offering size and listing date can be confirmed in the listing disclosure and securities registration statement.
Get free 레메디 email updates.
Bullstory sends one daily email when new analysis or important company news is available.

After failing to clear the listing threshold twice, Remedy has newly listed on KOSDAQ after a third attempt. 7in the third week of the month (13~17day) and is part of the initial public offering schedule.
Remedy had a record of failing to complete a listing in its previous two attempts. This time, after a third offering process, it entered the KOSDAQ market.
A company that succeeds in listing after going through three rounds of offerings and reviews is called a three-time listing hopeful. Remedy falls into this category.
Specific details such as the offering price, number of shares offered, lead underwriter, and listing date are stated in the securities registration statement and the listing disclosure documents submitted by the company. Investors can check those documents to confirm the exact figures and schedule information.
The securities registration statement and listing disclosure documents can be found on the Financial Supervisory Service’s electronic disclosure system and on the Korea Exchange’s listing disclosures. The company’s listing-related disclosures are used as key reference material for investment decisions.
This listing by Remedy is 7classified as a successful retry case in the IPO trend in the third week of the month. Please check the relevant disclosures for details on the size of the offering and the amount of shares available for trading.
Sources: 연합뉴스 경제
Bullstory synthesized this report from the linked sources. AI may have assisted the writing process. Check the original reports for factual confirmation.